Navigation

Anoro Ellipta

side effects drug center anoro ellipta (umeclidinium and vilanterol inhalation powder) drug - patient side effects and images

  • Related Drugs
    Atrovent HFA Atrovent Nasal Spray Atrovent Nasal Spray .06 Bevespi Aerosphere Breztri Aerosphere Duaklir Pressair Pulmicort Respules Serevent Diskus Spiriva Respimat Ventolin HFA Ventolin Solution Ventolin Syrup Yupelri
  • Drug Comparison
    Anoro Ellipta vs. Stiolto Respimat

    •  

    PROFESSIONAL

    CONSUMER

    SIDE EFFECTS

    Anoro Ellipta Patient Information Including Side Effects

    Brand Names: Anoro Ellipta

    Generic Name: umeclidinium and vilanterol

    What is umeclidinium and vilanterol (Anoro Ellipta)?

    Umeclidinium and vilanterol is a combination medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

    This medicine is for use only in people with COPD and should not be used to treat asthma.

    Umeclidinium and vilanterol may also be used for purposes not listed in this medication guide.

    What are the possible side effects of umeclidinium and vilanterol (Anoro Ellipta)?

    Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

    Call your doctor at once if you have:

    • wheezing, choking, or other breathing problems after using this medicine;
    • painful or difficult urination, or urinating more often;
    • blurred vision, tunnel vision, eye pain or redness, or seeing halos around lights;
    • high blood sugar--increased thirst or urination, hunger, dry mouth, fruity breath odor; or
    • low potassium level--leg cramps, constipation, irregular heartbeats, fluttering in your chest, numbness or tingling, muscle weakness or limp feeling.

    Common side effects may include:

    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    What is the most important information I should know about umeclidinium and vilanterol (Anoro Ellipta)?

    You should not use this medicine if you are allergic to umeclidinium or vilanterol, or if you have a severe allergy to milk proteins.

    Umeclidinium and vilanterol is not a rescue medicine. It will not work fast enough to treat an bronchospasm attack.

    Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.

    Anoro Ellipta Patient Information including How Should I Take

    What should I discuss with my healthcare provider before using umeclidinium and vilanterol (Anoro Ellipta)?

    You should not use this medicine if you are allergic to umeclidinium or vilanterol, or if you have a severe allergy to milk proteins.

    Tell your doctor if you have ever had:

    Tell your doctor if you are pregnant or breastfeeding.

    Umeclidinium and vilanterol is not approved for use by anyone younger than 18 years old.

    How should I use umeclidinium and vilanterol (Anoro Ellipta)?

    Follow all directions on your prescription label and read all medication guides. Use the medicine exactly as directed.

    Umeclidinium and vilanterol is not a rescue medicine for bronchospasm attacks. Use only fast-acting inhalation medicine for an attack. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working as well.

    Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.

    Use the medicine at the same time each day, and not more than once in a 24-hour period.

    Store at room temperature away from moisture, heat, and light. Keep the inhaler device in the sealed foil tray until ready to start using it.

    Throw the inhaler away 6 weeks after opening, or when the dose indicator shows a zero (whichever comes first).

    Anoro Ellipta Patient Information including If I Miss a Dose

    What happens if I miss a dose (Anoro Ellipta)?

    Use the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not use two doses at one time. Do not use more than once in a 24-hour period.

    What happens if I overdose (Anoro Ellipta)?

    Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

    Overdose symptoms may include include headache, chest pain, fast heart rate, tremor, and feeling shaky or nervous.

    What should I avoid while using umeclidinium and vilanterol (Anoro Ellipta)?

    Do not use a second inhaled bronchodilator that contains formoterol, arformoterol, indacaterol, olodaterol, salmeterol, or vilanterol.

    What other drugs will affect umeclidinium and vilanterol (Anoro Ellipta)?

    Tell your doctor about all your other medicines, especially:

    This list is not complete. Other drugs may affect umeclidinium and vilanterol, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

    Where can I get more information (Anoro Ellipta)?

    Your pharmacist can provide more information about umeclidinium and vilanterol.

    Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
    Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Copyright 1996-2021 Cerner Multum, Inc.